Info@ThinkPinkRocks.com

Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

PharmaEssentia (Taipei, Taiwan) and AOP Orphan (Vienna, Austria) announce the completion of recruitment for the Phase III trial PROUD-PV to support global marketing of P1101 (Ropeginterferon alfa-2b), a novel, long-acting, mono-pegylated interferon for the first line treatment of polycythemia vera.

Link:
Recruitment completed for Phase III PROUD-PV trial of P1101 for treatment of polycythemia vera

Share

Leave a Reply

Solve : *
19 + 16 =